Form 4: Cyanotech Director Michael Davis Increases Stake in Company
SEC Form 4 Filing
Director Michael Davis reports purchasing additional shares of Cyanotech Corp through a 10b5-1 plan.
Summary
- Michael Davis, a director and 10% owner of Cyanotech Corporation, has reported purchasing 5,000 shares on July 8, 2024, at $0.32 per share and another 5,000 shares on July 9, 2024, at $0.39 per share.
- These transactions were made under a pre-arranged 10b5-1(c) plan adopted on March 6, 2024.
- Following these purchases, Davis indirectly owns 1,066,736 shares through a revocable trust.
- Davis also has indirect ownership through his spouse (31,250 shares), as co-trustee for the Nyracai Davis Irr. Trust and the Nettizanne J. Davis Irr. Trust (150,000 shares), and as trustee for other trusts (58,000 and 58,789 shares).
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The director's purchase indicates confidence, but it's part of a pre-arranged plan, so it's not a strong signal.
Positives
- A director increasing their stake in the company can be seen as a positive signal to the market.
Industry Context
Insider buying is often viewed positively, suggesting confidence in the company's future prospects. However, it's essential to consider the context, such as the size of the purchase relative to the director's existing holdings and the overall market conditions.
Comparison to Industry Standards
- Comparing insider trading activity at Cyanotech to similar companies in the algae-based products or nutritional supplement industries could provide further insights.
- For example, monitoring insider activity at companies like Corbion (which produces algae-based ingredients) or nutraceutical firms could offer a benchmark.
- Analyzing the frequency and size of insider transactions relative to market capitalization can help determine the significance of this activity.
Stakeholder Impact
- The director's increased stake could positively influence shareholder confidence.
- There is no immediate impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 03-06-2024 | Adoption date of the 10b5-1(c) plan |
| 07/08/2024 | Date of first reported transaction: purchase of 5,000 shares at $0.32 |
| 07/09/2024 | Date of second reported transaction: purchase of 5,000 shares at $0.39 |
| 07/10/2024 | Date of Form 4 filing |
Keywords
Cyanotech, Michael Davis, insider trading, Form 4, share purchase, 10b5-1 plan, beneficial ownership, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.